Search research articles
Contact Us
Filters
Showing results (221-230 of 283) with videos related to
Page
of 29
Sort By:
Cell Reports
|
December 8, 2021
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis
Massimiliano Di Filippo, Andrea Mancini, Laura Bellingacci, et al.
NPJ Parkinson'S Disease
|
November 30, 2024
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson's Disease
Federica Servillo, Maria De Carluccio, Giulia Di Lazzaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 12, 2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
Flora H Duits, Charlotte E Teunissen, Femke H Bouwman, et al.
Journal of Clinical Medicine
|
May 25, 2024
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson's Disease: A Retrospective Study by Different Expert Centers
Maria Felice Ghilardi, Angelo Quartarone, Alessandro Di Rocco, et al.
Frontiers in Aging Neuroscience
|
January 9, 2019
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [<sup>18</sup>F]-Flutemetamol PET Scan Result
Sarah Westwood, Alison L Baird, Abdul Hye, et al.
Stroke Research and Treatment
|
November 8, 2018
Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study
Ilaria Maestrini, Marta Altieri, Laura Di Clemente, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers
Moira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2018
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
Diego Albani, Moira Marizzoni, Clarissa Ferrari, et al.
JAMA
|
July 23, 2009
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
Niklas Mattsson, Henrik Zetterberg, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD
|
April 9, 2019
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease
Moira Marizzoni, Clarissa Ferrari, Ambra Macis, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 283) with videos related to
Sort By:
Page
of 29
Cell Reports
|
December 8, 2021
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis
Massimiliano Di Filippo, Andrea Mancini, Laura Bellingacci, et al.
NPJ Parkinson'S Disease
|
November 30, 2024
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson's Disease
Federica Servillo, Maria De Carluccio, Giulia Di Lazzaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 12, 2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
Flora H Duits, Charlotte E Teunissen, Femke H Bouwman, et al.
Journal of Clinical Medicine
|
May 25, 2024
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson's Disease: A Retrospective Study by Different Expert Centers
Maria Felice Ghilardi, Angelo Quartarone, Alessandro Di Rocco, et al.
Frontiers in Aging Neuroscience
|
January 9, 2019
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [<sup>18</sup>F]-Flutemetamol PET Scan Result
Sarah Westwood, Alison L Baird, Abdul Hye, et al.
Stroke Research and Treatment
|
November 8, 2018
Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study
Ilaria Maestrini, Marta Altieri, Laura Di Clemente, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers
Moira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2018
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
Diego Albani, Moira Marizzoni, Clarissa Ferrari, et al.
JAMA
|
July 23, 2009
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
Niklas Mattsson, Henrik Zetterberg, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD
|
April 9, 2019
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease
Moira Marizzoni, Clarissa Ferrari, Ambra Macis, et al.
Page
of 29